Acta Med. 2012, 55: 111-115

https://doi.org/10.14712/18059694.2015.47

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy

Zuzana Janovská

Charles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Czech Republic: Department of Dentistry

Received April 21, 2012
Accepted September 10, 2012

Crossref Cited-by Linking

  • Nah Haram, Lee Donghyun, Lee Jae Seo, Lee Sang Jin, Heo Dong Nyoung, Lee Yeon-Hee, Bang Jae Beum, Hwang Yu-Shik, Moon Ho-Jin, Kwon Il Keun: Strategy to inhibit effective differentiation of RANKL-induced osteoclasts using vitamin D-conjugated gold nanoparticles. Applied Surface Science 2020, 527, 146765. <https://doi.org/10.1016/j.apsusc.2020.146765>
  • Gupta Ayushman, Jayes Leah R, Holmes Steve, Sahota Opinder, Canavan Melissa, Elkin Sarah L, Lim Kelvin, Murphy Anna C, Singh Sally, Towlson Elizabeth A, Ward Helen, Scullion Jane, McKeever Tricia M, Bolton Charlotte E:

    Management of Fracture Risk in Patients with Chronic Obstructive Pulmonary Disease (COPD): Building a UK Consensus Through Healthcare Professional and Patient Engagement

    . COPD 2020, Volume 15, 1377. <https://doi.org/10.2147/COPD.S233398>
  • Park Peter Sang Uk, Mun Se Hwan, Zeng Steven L., Kim Haemin, Bae Seyeon, Park-Min Kyung-Hyun: NRF2 Is an Upstream Regulator of MYC-Mediated Osteoclastogenesis and Pathological Bone Erosion. Cells 2020, 9, 2133. <https://doi.org/10.3390/cells9092133>
  • Barngkgei Imad, Halboub Esam, Almashraqi Abeer: Effect of bisphosphonate treatment on the jawbone: an exploratory study using periapical and panoramic radiographic evaluation. Oral Radiol 2019, 35, 159. <https://doi.org/10.1007/s11282-018-0358-4>
  • Nishiguchi Akihiro, Taguchi Tetsushi: Osteoclast-Responsive, Injectable Bone of Bisphosphonated-Nanocellulose that Regulates Osteoclast/Osteoblast Activity for Bone Regeneration. Biomacromolecules 2019, 20, 1385. <https://doi.org/10.1021/acs.biomac.8b01767>
  • Barngkgei Imad, Khattab Razan: Detecting the effect of bisphosphonates during osteoporosis treatment on jawbones using multidetector computed tomography: The OSTEOSYR project. J Invest Clin Dent 2018, 9, e12332. <https://doi.org/10.1111/jicd.12332>
  • Cecchinato Francesca, Atefyekta Saba, Wennerberg Ann, Andersson Martin, Jimbo Ryo, Davies Julia R.: Modulation of the nanometer pore size improves magnesium adsorption into mesoporous titania coatings and promotes bone morphogenic protein 4 expression in adhering osteoblasts. Dental Materials 2016, 32, e148. <https://doi.org/10.1016/j.dental.2016.04.002>
  • Heggendorn Fabiano Luiz, Leite Taiana Campos, Cunha Karin Soares Gonçalves, Junior Arley Silva, Gonçalves Lucio Souza, da Costa Karla Bianca Fernandes Fontes, Dias Eliane Pedra: Bisphosphonate-related osteonecrosis of the jaws: Report of a case using conservative protocol. Spec Care Dentist 2016, 36, 43. <https://doi.org/10.1111/scd.12143>
  • Watson J. Tracy, Nicolaou Daemeon A.: Orthobiologics in the Augmentation of Osteoporotic Fractures. Curr Osteoporos Rep 2015, 13, 22. <https://doi.org/10.1007/s11914-014-0249-5>
  • Shintani Tomoaki, Miyauchi Mutsumi, Tani Ryouji, Yoshioka Yukio, Akagi Eri, Toratani Shigeaki, Okamoto Tetsuji: Bisphosphonate-related osteonecrosis of the jaw successfully treated with surgical resection and its histopathological features: A long-term follow-up report. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2015, 27, 283. <https://doi.org/10.1016/j.ajoms.2014.02.004>
  • GÜNALDI MERAL, AFSAR CIGDEM USUL, DUMAN BERNA BOZKURT, KARA ISMAIL OGUZ, TATLI UFUK, SAHİN BERKSOY: Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncology Letters 2015, 10, 439. <https://doi.org/10.3892/ol.2015.3156>
  • Janovska Zuzana, Mottl Radovan, Slezak Radovan: Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015, 159, 313. <https://doi.org/10.5507/bp.2013.069>
  • Sparabombe Scilla, Vitali Lucia, Nori Alessandra, Berlin Ricarda Sara, Mazur Marta, Orsini Giovanna, Putignano Angelo: Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months. International Journal of Dentistry 2014, 2014, 1. <https://doi.org/10.1155/2014/475859>
  • McClelland Descalzo Darcie L, Ehnes Devon D, zur Nieden Nicole I: Stem cells for osteodegenerative diseases: current studies and future outlook. Regenerative Medicine 2014, 9, 219. <https://doi.org/10.2217/rme.13.100>
  • Raita Yuki, Komatsu Koichiro, Nifuji Akira, Sato Mitsunobu, Morito Mitsuhiko, Hayakawa Tohru: Promotion of Bone Formation around Alendronate-immobilized Screw-Type Titanium Implants after Implantation into Rat Molar Tooth Sockets. J. Hard Tissue Biology. 2014, 23, 177. <https://doi.org/10.2485/jhtb.23.177>
  • Xu Xiao-Long, Gou Wen-Long, Wang Ai-Yuan, Wang Yu, Guo Quan-Yi, Lu Qiang, Lu Shi-Bi, Peng Jiang: Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?. J Transl Med 2013, 11. <https://doi.org/10.1186/1479-5876-11-303>
Crossref Cited-by Linking logo